525 related articles for article (PubMed ID: 23294530)
1. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
[TBL] [Abstract][Full Text] [Related]
2. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
3. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients.
Stanojevic S; Ratjen F; Stephens D; Lu A; Yau Y; Tullis E; Waters V
J Cyst Fibros; 2013 Dec; 12(6):575-83. PubMed ID: 23757360
[TBL] [Abstract][Full Text] [Related]
5. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
6. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
Goss CH; Mayer-Hamblett N; Aitken ML; Rubenfeld GD; Ramsey BW
Thorax; 2004 Nov; 59(11):955-9. PubMed ID: 15516471
[TBL] [Abstract][Full Text] [Related]
7. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
[TBL] [Abstract][Full Text] [Related]
8. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.
Hansen CR
Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659
[TBL] [Abstract][Full Text] [Related]
10. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
Goss CH; Otto K; Aitken ML; Rubenfeld GD
Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
[TBL] [Abstract][Full Text] [Related]
12. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis.
Stephenson AL; Sykes J; Berthiaume Y; Singer LG; Aaron SD; Whitmore GA; Stanojevic S
J Heart Lung Transplant; 2015 Sep; 34(9):1139-45. PubMed ID: 26087666
[TBL] [Abstract][Full Text] [Related]
13. Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.
Barsky EE; Williams KA; Priebe GP; Sawicki GS
Pediatr Pulmonol; 2017 Oct; 52(10):1276-1282. PubMed ID: 28815999
[TBL] [Abstract][Full Text] [Related]
14. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
[TBL] [Abstract][Full Text] [Related]
15. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
[TBL] [Abstract][Full Text] [Related]
16. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
18. Impact of burkholderia infection on lung transplantation in cystic fibrosis.
Murray S; Charbeneau J; Marshall BC; LiPuma JJ
Am J Respir Crit Care Med; 2008 Aug; 178(4):363-71. PubMed ID: 18535253
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.
Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V
J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471
[TBL] [Abstract][Full Text] [Related]
20. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
